Semaglutide (Wegovy and Ozempic) is an FDA-approved GLP-1 agonist that is used to treat obesity, type 2 diabetes, and weight-related health conditions such as metabolic dysfunction-associated steatohepatitis (MASH)
Results accelerated over time At month 1, both treatment groups showed modest gains (10.5 and 11.3 hairs) while placebo declined (-3.6)
In this article, Ill explore those benefits, how to work with semaglutide temporarily while restoring your bodys natural GLP-1 production, risks and side effects to be mindful of, and more answers to the most common questions I get about this therapy
Gastrointestinal effects Nausea, constipation , diarrhea , and reduced appetite are the most common side effects with both medications
Compounded semaglutide and tirzepatide prepared by licensed 503A compounding pharmacies are legal and regulated at both state and federal levels
GLP-1 has shifted the idea that weight loss is part of a willpower narrative and toward a biology- and science-first framing centered on the gut-brain axis